MP
MPL.AU Medibank Private Ltd
- Market cap
- AUD 14.0B
- P/E
- 22.1x
- P/B
- 5.77x
- ROE
- 26.3%
- Dividend yield
- 3.63%
- Fundamental score
- 3.3/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is MPL.AU undervalued?
Graham numberMPL.AU trades 138.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Medibank Private Ltd fundamental analysis
13 of 18 checks passedROE 2/2
High return on equity (26.3%), above 20%.
ROA 1/1
Return on assets (13.4%) is above the industry median (6.1%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (27.5%) is above the 5-year average (7.7% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (27.5%) is above the industry median (-13.2%).
Revenue Growth 1/2
Revenue grew 8.0% a year over the past 3 years.
Leverage 2/2
Total assets are 2.0x equity, within a prudent level for a financial company.
Equity Growth 1/1
Shareholders' equity grew over the past 5 years.
PE vs Market 0/1
PE (22.1x) is above the market median (15.0x).
PE vs Industry 0/1
PE (22.1x) is above the industry median (20.7x).
PBV 0/1
Price to book (5.8x) is above the industry median (2.2x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 127.6, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 2.88, above 1.
Dividend Yield 1/2
Dividend yield (3.6%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 1/2
Dividends paid without a cut of more than 10% for 6 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 79.8%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Medibank Private Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Medibank Private Ltd
Medibank Private Limited provides private health insurance in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services comprising dental, optical, and physiotherapy, as well as offers health insurance p…
Full company profileMedibank Private Ltd financial statements
Medibank Private Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 6.95B | 6.58B | 6.77B | 6.83B | 6.98B | 7.09B | 7.40B | 8.02B | 8.56B | 9.33B |
| Gross Profit | 6.95B | 6.58B | 6.77B | 6.83B | 7.03B | 7.10B | 7.40B | 8.02B | 8.56B | 1.60B |
| Operating Income | 629M | 598M | 616M | 454M | 6.32B | 558M | 443M | 7.00B | 7.90B | 928M |
| EBITDA | 714M | 694M | 721M | -3.40M | 715M | 635M | 521M | 807M | 751M | 1.05B |
| Net Income | 450M | 445M | 459M | 315M | 441M | 394M | 511M | 493M | 501M | 639M |
| EPS | 0.16 | 0.16 | 0.17 | 0.11 | 0.16 | 0.14 | 0.19 | 0.18 | 0.18 | 0.23 |
| Balance Sheet | ||||||||||
| Total Assets | 3.46B | 3.54B | 3.63B | 3.75B | 3.92B | 4.55B | 4.39B | 4.69B | 4.70B | 4.75B |
| Total Liabilities | 34.1M | 43.3M | 45.6M | 1.95B | 2.02B | 2.61B | 2.30B | 2.38B | 2.36B | 2.34B |
| Shareholders' Equity | 1.72B | 1.83B | 1.94B | 1.80B | 1.91B | 1.95B | 2.08B | 2.31B | 2.34B | 2.43B |
| Cash & Short-term Investments | 595M | 470M | 657M | 871M | 672M | 831M | 695M | 928M | 874M | 570M |
| Total Debt | - | - | - | 109M | 93.4M | 76.9M | 55.3M | 218M | 209M | 274M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 393M | 408M | 416M | 572M | 482M | 949M | 185M | 869M | 381M | 623M |
| Capital Expenditure | 5.50M | 3.80M | 9.80M | 29.3M | 35.1M | 35.1M | 41.9M | 57.6M | 11.2M | 19.4M |
| Free Cash Flow | 388M | 405M | 406M | 543M | 447M | 913M | 143M | 811M | 370M | 603M |
| Ratios | ||||||||||
| ROE | 26.1% | 24.3% | 23.7% | 17.5% | 23.1% | 20.2% | 24.5% | 21.4% | 21.4% | 26.3% |
| ROA | 13.0% | 12.6% | 12.6% | 8.4% | 11.2% | 8.7% | 11.6% | 10.5% | 10.7% | 13.4% |
| Net Profit Margin | 6.5% | 6.8% | 6.8% | 4.6% | 6.3% | 5.6% | 6.9% | 6.1% | 5.9% | 6.8% |
| Debt to Equity | - | - | - | 0.06x | 0.05x | 0.04x | 0.03x | 0.09x | 0.09x | 0.11x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Medibank Private Ltd dividends
- Dividend yield
- 3.63%
- Forward dividend
- 0.19 AUD
- Payout ratio
- 79.8%
- Ex-dividend date
- Sep 2, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | AUD 510M | 0.19 | 79.8% |
| 2025 | AUD 474M | 0.17 | 94.6% |
| 2024 | AUD 427M | 0.16 | 86.7% |
| 2023 | AUD 375M | 0.14 | 73.3% |
| 2022 | AUD 358M | 0.13 | 90.9% |
| 2021 | AUD 333M | 0.12 | 75.5% |
| 2020 | AUD 430M | 0.16 | 136.4% |
| 2019 | AUD 355M | 0.13 | 77.5% |
| 2018 | AUD 337M | 0.12 | 75.8% |
| 2017 | AUD 310M | 0.11 | 68.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Medibank Private Ltd
- Insiders 0.15%
- Institutions 55.78%
- Public & others 44.07%
- Shares outstanding 2.75B
- Free float 2.75B
Top funds holding MPL.AU
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 42.4M | 1.54% | - | Oct 2020 |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 17.6M | 0.64% | - | Dec 2020 |
| iShares Core MSCI EAFE ETF | 12.4M | 0.45% | - | Feb 2021 |
| iShares MSCI Eafe ETF | 9.10M | 0.33% | - | Feb 2021 |
| iShares MSCI EAFE Minimum Volatility ETF | 5.92M | 0.21% | - | Feb 2021 |
| Fidelity International Index Fund | 5.41M | 0.20% | - | Feb 2021 |
| JP Morgan ETF Tr-BetaBuilders Developed Asia ex-Japan ETF | 5.11M | 0.19% | - | Feb 2021 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund | 4.97M | 0.18% | - | Oct 2020 |
| DFA International Core Equity Portfolio | 4.03M | 0.15% | - | Jan 2021 |
| iShares MSCI Eafe Growth ETF | 3.65M | 0.13% | - | Feb 2021 |
Medibank Private Ltd company profile
- Company name
- Medibank Private Ltd
- Ticker
- MPL.AU
- ISIN
- AU000000MPL3
- Exchange
- Australian Securities Exchange
- Sector
- Financial Services
- Industry
- Insurance
- Employees
- 5,001
- Fiscal year end
- June
- Address
- 695 Collins Street, Docklands, VIC, Australia, 3008
- Phone
- 61 3 8622 5222
- Website
- medibank.com.au
About Medibank Private Ltd
Medibank Private Limited provides private health insurance in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services comprising dental, optical, and physiotherapy, as well as offers health insurance products to overseas visitors and students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth and primary care services to government and corporate customers; and distributes travel, life, and pet insurance products; It underwrites and distributes private health insurance policies under the Medibank and ahm brands for resident and nonresident customers, broader community with wellbeing, prevention, primary care and homecare, with investments in short stay surgical and mental health facilities. The company was founded in 1976 and is based in Docklands, Australia.
Medibank Private Ltd management
10- Mr. David Koczkar B.Com., MAICD, PGDipFinanceCEO, MD & Director · born 1973
- Mr. Mark Rogers B.Sc., BEng (Hons)Group Lead - Chief Financial Officer & Group Strategy
- Mr. Milosh MilisavljevicGroup Lead - Chief Customer Officer
- Mr. Robert Read B.A., BA(Psych), BComm(Mgt), GAICDGroup Lead ? Amplar Health
- Ms. Felicia TrewinGroup Lead ? Data & Technology
- Colette CampbellSenior Executive of Investor Relations
- Ms. Mei Ramsay B.A., L.L.B., L.L.M.Group Lead ? Trust, Legal, Group General Counsel & Company Secretary
- Ms. Emily RitchieSenior Executive of External Affairs
- Ms. Kylie Bishop B.A., BA (Hons) Psy, MOrgPsychGroup Lead ? People, Spaces, Culture & Sustainability
- Dr. Andrew Wilson FACHSE, FRANZCP, M.M., MBBSGroup Chief Medical Officer